Blog - Page 398 of 873

June 1, 2021June 1, 2021

Lucere Dermatology & Laser Clinic Joins FYidoctors

FYidoctors announced Lucere Dermatology & Laser Clinics as the latest esthetic medicine practice to join the growing company. The addition of Lucere’s two new Edmonton clinics brings the total aesthetic medicine clinics operating in Western Canada for FYidoctors to 11.

“We’re pleased to announce the merger with Lucere, and to partner with Dr. Taher and his experienced team,” said Dr. Alan Ulsifer, CEO and Chairman of FYidoctors. “Regarded as a leading medical aesthetics practice in Edmonton, we look forward to building on our shared approach to patient-led care.”

Founded by Dr. Zaki Taher and Issan Sassi, the husband-and-wife duo have led the full service medical and cosmetic dermatology clinics since 2014. Dr. Taher received both his Bachelor of Medical Sciences and Medical Doctorate from the University of Alberta and is recognized as one of the few fellowship-trained laser surgeons and cosmetic dermatologists in Canada. Issan, who leads operations and marketing for the clinics, holds a Bachelor of Science in Immunology and Infection from the University of Alberta, and an After Degree in Environmental Public Health from Concordia University College.

“In partnering with FYidoctors, we saw alignment not only with how we envisioned Lucere’s growth in the future, but with the shared mission and values of the company,” said Dr. Taher, Founder of Lucere.

An engaged and respected local business in the Edmonton community, Lucere was recently awarded the Top Choice Awards’ ‘Top Cosmetic Clinic’ and rated the ‘Top Dermatology Clinic’ by Best in Edmonton, and supports several local non-profits including Lois Hole Hospital for Women, Zebra Centre, the Juvenile Diabetes Research Foundation, and many others.

Click HERE for the full press release.

New Paper Establishes Context for Myopia Control Axial Length Targets

A new paper that has been accepted for publication in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists (UK), furthers understanding of myopia control efficacy in the context of normal childhood eye growth. Axial Length Targets for Myopia Control (Chamberlain P, et al.) is now available online via Open Access.

Since young eyes grow, even when not myopic, the paper compares axial elongation among children who remain emmetropic, children with untreated myopia progression, and children with myopia managed with CooperVision MiSight^® 1 day myopia control lenses. The comparison uses data from the three-year MiSight^®1 day clinical study, the Orinda Longitudinal Study of Myopia (OLSM) and the Singapore Cohort Study of the Risk Factors for Myopia (SCORM).

The analysis revealed that the predicted three-year axial elongation for emmetropic children (0.24 mm) is similar to the mean three-year elongation in MiSight^® 1 day-treated children with myopia (0.30 mm). In contrast, the axial elongation (0.63 mm) observed in the control group in the MiSight^® 1 day clinical study was much higher, and similar to virtual cohorts based on the OLSM (0.70 mm) and SCORM (0.65 mm) models for myopia development.

This observation suggests that while abnormal myopic eye growth may be managed with MiSight^® 1 day in age-appropriate children, normal, physiological eye growth may continue as the child ages. It supports the hypothesis that myopic axial elongation may be superimposed on underlying physiological axial elongation.

“Some eye growth as part of the aging process is normal—myopic axial elongation is not. Our work further validates that evidence-based interventions can be highly effective in slowing that myopic eye growth,” said Paul Chamberlain, BSc (Hons), MCOptom, the paper’s lead author and Director of Research Programs for CooperVision.

“In assessing treatment effectiveness, we caution our industry away from applying arbitrary correction factors to account for normal, physiological eye growth until this has been better understood. Efficacy percentages may seem higher presented in that light, but it complicates understanding and valid comparisons,” said co-author Mark Bullimore, MCOptom, PhD, FAAO.

Click HERE for the full press release.

Safilo Builds on Its Partnership with Evonik to Introduce TROGAMID® myCX eCO in Lenses

Safilo is building on its 20-year partnership with specialty chemicals world leader Evonik to use their newest high-quality material TROGAMID® myCX eCO for premium sun lenses.

Safilo will debut sun lenses made of TROGAMID® myCX eCO in January 2022 with the BOSS Spring Summer collection. This high-performance polymer will be progressively rolled out across Safilo’s portfolio, especially in its Made in Italy brands.

TROGAMID® myCX eCO is a sustainable high-performance crystal-clear polymer made from 40% biomass and 100% renewable energy, which results in a 50% lower carbon footprint. It offers a transparency of more than 90%, outstanding mechanical properties, resistance to stress cracking and breakage. Safilo will be the first eyewear player to introduce this material – specially optimized for the optics industry – in one of its licensed brands.

“Sustainability is an integral part of the Safilo’s business philosophy and firmly rooted in our company strategy: this is why partnerships with materials leaders like Evonik continue to be so important as we push the boundaries of sustainable materials and accelerate the industry,” declares Vladimiro Baldin, Chief Licensed Brand and Global Product Officer at Safilo Group.

“It was particularly important for us to offer to a premium manufacturer like Safilo a sustainable polyamide whose properties differ in nothing from those of the TROGAMID® myCX they already use,” says Viviane Papa, who is responsible for Evonik’s high-performance polyamides granules and compounds business. “We at Evonik also follow a strong sustainability business philosophy and are working in many areas to make our products sustainable.”

Click HERE for the full press release.

May 27, 2021May 27, 2021

Weyburn Eye Care Clinic Joins FYidoctors

FYidoctors announces the addition of Weyburn Eye Care Clinic to its banner. The merger marks FYidoctors’ first optometry practice in the city of Weyburn, which is regarded as one of the growing regional centres in southeast Saskatchewan.

In operation since the 1940s, Weyburn Eye Care is the only vision care clinic in Weyburn. Led by optometrists Dr. Sonya Hung and Dr. Robert Labbie, the clinic provides complete and comprehensive eye care.

“Weyburn Eye Care Clinic has been the exclusive provider of quality, comprehensive eye care in the community for over 80 years,” said Dr. Alan Ulsifer, CEO and Chairman of FYidoctors. “The new partnership will continue to serve the Weyburn and surrounding areas through the patient-centric care they are accustomed to.”

“We’re thrilled to partner with an organization who, like us, share in the vision of enhancing the lives of patients through quality eye care,” said Dr. Robert Labbie. “In partnering, we join a growing team of experts, and have access to an abundance of resources and technological advances,” added Dr. Hung. “

A supporter of excellence outside the clinic’s doors too, Weyburn Eye Care has taken part in community initiatives and projects for decades including Family Place, the Weyburn Humane Society, United Way, and many others. This impactful work will continue through FYidoctors’ Enhancing Life Foundation.

Click HERE for the full press release.

RONOR Establishes Multidisciplinary Workforce: Anonymous Designers Society

RONOR announces the creation of the Anonymous Designers Society, a workforce dedicated to creating the new NORDIC, KING SIZE by Nordic and DIVINE frame collections to be released in September.

RONOR wanted to create unique frames designed both for the consumer and the optician in mind. The Anonymous Designers Society has rallied around a common vision of pooling their expertise to analyze all aspects to enhance functionality and fit while creating classical lines with just the right touch of audacity. Simplifying the work of the opticians was also at the forefront of the creative process. Hence the Fit to Form Function.

Here are the outlines of the Fit to Form approach that guided their work:

• All front proportions (eye size and bridge) are respected to ensure a perfect fit;

• The comfort of the end user was taken into account in the creation of each frame;

• The pantoscopic angle of all eyewear can be easily adjusted;

• The arms of the nose pads have been reworked to be refined and discreet. They are adjustable at any angle;

• The length of the stems corresponds to the front calibre;

• The ends of the acetate stems are thinner and more refined. The optician can precisely adjust their length;

• Cutting and mounting lenses are simple;

• All eyewear is made with cellulose acetate and stainless steel.

The collections will be unveiled in September 2021; some models are already on the market.

Click HERE for the full press release.

Lucere Dermatology & Laser Clinic Joins FYidoctors

New Paper Establishes Context for Myopia Control Axial Length Targets

Safilo Builds on Its Partnership with Evonik to Introduce TROGAMID® myCX eCO in Lenses

Weyburn Eye Care Clinic Joins FYidoctors

RONOR Establishes Multidisciplinary Workforce: Anonymous Designers Society

Featured Posts

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

Everyday Elegance, Effortlessly Styled

Eschenbach Introduces the New magno® DIGITAL Video Magnifier

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

Everyday Elegance, Effortlessly Styled

Eschenbach Introduces the New magno® DIGITAL Video Magnifier

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

Everyday Elegance, Effortlessly Styled

Eschenbach Introduces the New magno® DIGITAL Video Magnifier

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

Everyday Elegance, Effortlessly Styled

Eschenbach Introduces the New magno® DIGITAL Video Magnifier